Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 47 , ISSUE 4 ( October-December, 2013 ) > List of Articles

REVIEW ARTICLE

Recent Advances in the Diagnosis of Tuberculosis

Kapil Goyal, Kusum Sharma, Suma B Appannanavar

Citation Information : Goyal K, Sharma K, Appannanavar SB. Recent Advances in the Diagnosis of Tuberculosis. J Postgrad Med Edu Res 2013; 47 (4):181-187.

DOI: 10.5005/jp-journals-10028-1083

Published Online: 00-12-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Sharma K, Appannanavar SB, Goyal K, Sharma A. Recent Advances in the Diagnosis of Tuberculosis. J Postgrad Med Edu Res 2013;47(4):181-187.


PDF Share
  1. Wkly Epidemiol Rec 2003;11;78(15):122-128.
  2. Diagnosis of tuberculosis. Indian J Pediatr 2000;67(2 Suppl):S3-8.
  3. Extrapulmonary tuberculosis. Indian J Med Res 2004;120(4):316-353.
  4. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr 2011;78(3):321-327.
  5. Extrapulmonary TB: what you need to know. Nurse Pract 2007;32(8):44-49.
  6. Multidrug-resistant tuberculosis. BMC Infect Dis 2008;8:10
  7. The TDR tuberculosis strain bank: a resource for basic science, tool development and diagnostic services. Int J Tuberc Lung Dis 2012;16(1):24-31.
  8. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis 2011; 64(4):265-71.
  9. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 2002;40(2):607-610.
  10. The Cy Scope(R) fluorescence microscope, a reliable tool for tuberculosis diagnosis in resource-limited settings. Am J Trop Med Hyg 2010;83(4):906-908.
  11. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6(9):570-581.
  12. Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosisendemic region. Int J Tuber Lung Dis 2011;15(4):483-488.
  13. Light emitting diodes for auramine O fluorescence microscopic screening of Mycobacterium tuberculosis. Int J Tuber Lung Dis 2006;10(9):1060-1062.
  14. Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J Med Microbiol 2009;27(3):217-221.
  15. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355(15):1539-50.
  16. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One 2009;4(12):e8341
  17. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2010;10(10):688-698.
  18. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Vietnam. BMC Infect Dis 2012;12:49
  19. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis. Indian J Med Microbiol 2012;30(1):64-68.
  20. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. J Microbiol Methods 2012;88(1):122-126.
  21. Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of Mycobacterium tuberculosis in smear-positive sputum. (Article in Chinese). Zhonghua Yu Fang Yi Xue Za Zhi 2011;45(1):21-25.
  22. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 2011;183(10):1427-1433.
  23. Reliability of the MODS assay decentralisation process in three health regions in Peru. Int J Tuber Lung Dis 2011;15(2):217-22.
  24. Utility of microscopic observation of drug susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuber 2010;57(4):207-212.
  25. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol 2010;48(12):4573-4579.
  26. Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol 2011;18(10):1616-1627.
  27. Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis 2001;20(10): 724-731.
  28. Direct detection of Mycobacterium tuberculosis in respiratory samples from patients in Scandinavia by polymerase chain reaction. Clin Microbiol Infect 1996;2(2):127-131.
  29. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007;45(6):1936-1940.
  30. Evaluation of a PCR assay for detection of Mycobacterium tuberculosis in clinical specimens. Diagn Microbiol Infect Dis 1995;22(4):357-360.
  31. Comparison of amplified Q beta replicase and PCR assays for detection of Mycobacterium tuberculosis. J Clin Microbiol 1995;33(4):860-867.
  32. Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium tuberculosis and other mycobacteria. Nucleic Acids Res 1994;22(13):2670-2677.
  33. Utility of polymerase chain reaction for detecting Mycobacterium tuberculosis in specimens from percutaneous transthoracic needle aspiration. Radiology 2002;225(1):205-209.
  34. Comparison of an internally controlled, largevolume light cycler assay for detection of Mycobacterium tuberculosis in clinical samples with the cobas amplicor assay. J Clin Microbiol 2005;43(4):1564-1569.
  35. Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR. J Clin Microbiol 2002; 40(11):4230-4234.
  36. Current issues on molecular and immunological diagnosis of tuberculosis. Yonsei Med J 2007;48(3):347-359.
  37. Evaluation of polymerase chain reaction using protein b primers for rapid diagnosis of tuberculous meningitis. Neurol India 2010;58(5):727-731.
  38. Multiplex PCR for rapid diagnosis of tuberculous meningitis. J Neurol 2011;258(10):1781-1787.
  39. Does multiplex polymerase chain reaction increase the diagnostic percentage in osteoarticular tuberculosis? A prospective evaluation of 80 cases. Int Orthop 2012;36(2):255-259.
  40. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthal Inflamm Infect 2013,3:25.
  41. Multiplex PCR for rapid diagnosis of gastrointestinal tuberculosis. J Global infect Dis (In press).
  42. Evaluation of multiplex PCR for rapid diagnosis of female genital tract tuberculosis. Indian J Med Sci (In press).
  43. Development of a new sensitive and efficient multiplex polymerase chain reaction (PCR) for identification and differentiation of different mycobacterial species. Trop Med Int Health 2003;8(2):150-157.
  44. PCR detection of coinfection with Mycobacterium tuberculosis and Mycobacterium avium in AIDS pateints with meningitis. J Med Microbiol 2012;61(Pt 12):1789-1791.
  45. Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients. J Med Microbiol 2008;57(Pt 4):439-443.
  46. Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis. Int J Tuber Lung Dis 2011;15(9):1211-1217.
  47. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363(11):1005-1015.
  48. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 2011;49(7):2540-2545.
  49. Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB). WHO Expert Group Report 2008:1-33. (Available at: http://www.who.int/tb/features_archive/expert_group_report_june08.pdf.
  50. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005;5:62
  51. Implementation of the INNO-Li PA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Int J Tuberc Lung Dis 2011;15(11):1546-1552.
  52. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis 2011 15(1):110-115.
  53. Molecular identification and characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line probe assay: an approach for rapid diagnosis of multidrug-resistant tuberculosis. Lett Appl Microbiol 2008;47(3):214-220.
  54. Multi-drug resistant tuberculosis and the red queen-diagnosis speed is crucial [Article in Portuguese]. Rev Port Pneumol 2007;13(6):869-877.
  55. Characterization of rpo B mutations by line probe assay in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from the aegean region in Turkey. Jpn J Infect Dis 2007;60(4):211-213.
  56. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif. TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol 2007; 45(9):3111-3114.
  57. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006;44(12):4384-4388.
  58. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006;12(5):752-759.
  59. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44(2):350-352.
  60. Direct application of the INNO-LiPA Rif. TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005;43(9):4880-4884.
  61. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003;41(9):4454-4456.
  62. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 2004;27(3):221-227.
  63. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J Med Res 2004;120(2):100-105.
  64. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J Med Res 2003;117:76-80.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.